Loncar Cancer Immunotherapy ETF (CNCR)

NASDAQ

Currency in USD

Disclaimer

11.55

+0.19(+1.66%)

Real-time Data02:21:48

Day's Range

11.40

11.55

52 wk Range

9.22

15.28

Day's Range

11.4011.55

52 wk Range

9.2215.28

Prev. Close: 11.36
Price Open: 11.40
Volume: 1,143
Average Volume (3m): 2,800
1-Year Change: -23%
Day's Range: 11.4-11.55
52 wk Range: 9.22-15.28
Market Cap: 11.71M

Total Assets: 22.61M
Shares Outstanding: 1,030,814
ROI (TTM): -
Dividends (TTM): -
Dividend Yield: -
Beta: -
Asset Class: Equity

Technical

Strong Sell

Sell

Neutral

Buy

Strong Buy

Strong Sell

Daily

Weekly

Monthly

Explore

Type:ETF

Market:United States

Issuer:ETF Series Solutions

Asset Class:Equity

People Also Watch

iShares MSCI Chile Capped

27.27

ECH

+1.53%

iShares Aaa - A Rated Corporate Bond

47.16

QLTA

+0.30%

iShares MSCI New Zealand Capped

46.86

ENZL

+1.87%

iShares MSCI South Africa

39.82

EZA

+0.30%

iShares MSCI Mexico Capped

63.94

EWW

+0.82%

How do you feel today about CNCR?

Vote to see community's results!

Loncar Cancer Immunotherapy ETF Analysis

Oil’s Iran Cliffhanger: What To Know And What To Expect
- ByBarani Krishnan
- •17 Aug 2022
- 28
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
How U.S. ETFs Fared In June
- ByTezcan Gecgil/Investing.com
- •01 July 2022
Wall Street struggled to regain ground in June amid unprecedented global macroeconomic headwinds, including intensifying geopolitical tensions, rising global financial uncertainty,...
May ETF Review: 40 Best, 29 Worst Fund Performers
- ByTezcan Gecgil/Investing.com
- •01 June 2022
Volatility continued to dominate Wall Street throughout May, as many investors seemed to have followed the adage 'sell in May, then go away.' As we write on May 31, the markets are...

Markets

S&P/ASX 200

7,178.40

+116.80

+1.65%

ASX 200 Futures

7,185.50

+108.5

+1.53%

ASX All Ordinaries

7,386.70

+116.90

+1.61%

US 500

4,564.90

-2.3

-0.05%

Dow Jones

36,132.63

+8.07

+0.02%

China A50 Futures

11,325.00

-14.0

-0.12%

Dollar Index

103.927

-0.068

-0.07%

Market Movers

Name	Last	Chg. %	Vol.
Woodside Energy	29.84	+1.05%	9.85M
Westpac Banking	21.79	+1.73%	9.70M
BHP Group Ltd	47.23	+1.53%	9.44M
ANZ Holdings	24.70	+1.27%	9.16M
National Australia Bank	29.32	+1.91%	7.49M
Commonwealth Bank Australia	106.34	+1.56%	3.14M
CSL	267.47	+1.65%	980.67K

Name	Last	Chg. %	Vol.
Lanthanein Resources	0.013	+116.67%	113.19M
Volt Power	0.002	+50.00%	250.00K
Winchester Energy Ltd	0.003	+50.00%	166.67K
8I Holdings Ltd	0.02	+42.86%	164.61K
AD1 Holdings	0.007	+40.00%	71.43K
Openlearning	0.02	+33.33%	50.00K
Ausmon Resources	0.004	+33.33%	115.00K

Name	Last	Chg. %	Vol.
Adherium Ltd	0.025	-44.44%	5.00
Adavale Resources Ltd	0.008	-27.27%	7.26M
Strategic Energy Resources	0.011	-26.67%	13.99M
BPH Global	0.002	-25.00%	1.75M
Kneomedia	0.003	-25.00%	201.23K
Noviqtech	0.003	-25.00%	2.46M
Discovex Resources	0.002	-25.00%	284.96K

Popular Searches

Please try another search

Loncar Cancer Immunotherapy ETF (CNCR)

People Also Watch

Loncar Cancer Immunotherapy ETF Analysis